- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03168932
Quantification of Fetal Brains' Sulci Along Gestation
Detecting and Quantifying Sulci and White Matter in Fetus' Brain Along the Third Stage of Gestation
Gyrogenesis is an ontogenic process that transforms the smooth (lissencephalic) cortex toward its mature, convolved (gyrencephalic) state. A tortuous, branching and deepening pattern of sulci and fissures outlines for a well-developed cortex.
The aim of this study is to find an algorithm that can detect the sulci in ultrasound images of fetus' brain and measure the length of it. This algorithm can be used for research demands like learning the development of the brain from embryo stages until the birth of the baby
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel
- Rambam Health Care Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant women between the ages of 18-35
- Gestational age between 25-40 weeks
- Low risk pregnancies
Exclusion Criteria:
- Multiple gestation
- Fetal brain abnormality
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
morphological changes of the developing fetal brain
Time Frame: 9 months
|
Ultrasound measurements of the fetal brain sulcation by a computerized algorithm
|
9 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0398-14-RMB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fetal Brain Injury
-
Hamisu SalihuCompletedFetal Body Size | Fetal Brain SizeUnited States
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Bnai Zion Medical CenterUnknown
-
HaEmek Medical Center, IsraelTerminatedFetal Ventricle Brain Asymmetry
-
Medical University of South CarolinaNational Institute of Neurological Disorders and Stroke (NINDS)CompletedBrain Injury | ChorioamnionitisUnited States
-
Washington University School of MedicineUniversity of California, Los Angeles; POM Wonderful LLCCompletedIntrauterine Growth RestrictionUnited States
-
Brigham and Women's HospitalUniversity of California, Los Angeles; POM Wonderful LLCCompletedIntrauterine Growth RestrictionUnited States
-
Brent MaselThe Moody FoundationCompletedChronic Traumatic Brain InjuryUnited States
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationUnknownBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
-
BrainScope Company, Inc.RecruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States